Key Contact Numbers If Your Patients Are Having Challenges With the Changes to OHIP+
Representatives from the ORA Board recently met with the MOHLTC to discuss the changes to OHIP+ that are now in effect. The following key contact numbers were provided by the Ministry and may […]
Imminent changes to OHIP+ will create access challenges for Ontario children who require medication
Daniel and Nathan are 8 year-old twin brothers with a rare and potentially lethal disease. Prior to receiving a new treatment that blocks an overproduced chemical in their immune system, they experienced frequent […]
Important Update for Temporary Facilitated Access Mechanism for Rheumatology and Changes to OHIP+
There is an important update on the Temporary Facilitated Access (TFA) mechanism for rheumatology, regarding the imminent changes on March 31, 2019. The ORA has been asked to pass along the attached letter […]
Ontario eConsult Service
The Ontario Rheumatology Association is working on improving patient access to specialist rheumatologic care across the province. One of the ways that this could be improved is enhanced access to subspecialist rheumatologists for […]
Drug Shortage Update – Methotrexate
There is a drug shortage update for Methotrexate. More information is available via this link: Drug Shortage MTX […]
Ondansetron for Methotrexate-Induced Nausea/Vomiting
The ORA EAP Committee met with the MOHLTC last year and submitted a request to have ondansetron funded for pediatric patients with rheumatic diseases who are receiving weekly oral or subcutaneous methotrexate. It […]
Updated Notice – Temporary Facilitated Access Mechanism
Please find the attached notice from the Executive Officer regarding an update to pharmacies about the claims submission process under the Temporary Facilitated Access Mechanism (TFA Rheumatology) using the Health Network System (HNS). […]
Health Canada and Biosimilar Drugs – Important Information for Healthcare Professionals
The following notice was received by the ORA from Health Canada on December 3, 2018: Health Canada’s Biologics and Genetic Therapies Directorate is asking healthcare professionals who prescribe, dispense or administer biologic drugs […]
Opportunity for Arthritis Health Professionals!
Do you know ou know or work with health professionals who want to stay current withevidence-based knowledge in the field of rheumatology and arthritis care? Please share this important information: AHPA Opportunities […]
A New Quality Standard is Now Available for Osteoarthritis
For further information, please visit this link: New Quality Standard – Osteoarthritis […]
